// App-Quantinova.ai

: The Association between the Alpha-Fibrinogen Thr312Ala (rs6050) Polymorphism and Risk of Venous Thromboembolism Among Enrollees in the Gate Study

Researchers

Presenter

  • Amanda B Payne

Principal Investigators

  • Christine De Staercke

  • Joshua W Francis

  • Harland D. Austin

  • Kavita N Patel

  • Christopher J. Bean

  • W. Craig Hooper

Medical Centers

  • National Center on Birth Defects and Developmental Disabilities, US Centers for Disease Control and Prevention, Atlanta, GA

  • Rollins School of Public Health, Department of Epidemiology, Emory University, Atlanta, GA

  • Emory + Children's Pediatric Institute, Aflac Cancer & Blood Disorders Center, Atlanta, GA

  • Department of Biostatistics of Emory University, Atlanta, GA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • Fibrinogen

Drug/Treatment

  • Fibrinogen (IV)

Outcome

  • N/A


Study Design

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A